Zosano Pharma to Report Fourth Quarter and 2015 Financial Results and to Provide a Corporate Update

FREMONT, Calif., March 21, 2016 -- Zosano Pharma Corporation (NASDAQ:ZSAN) today announced that it plans to report financial results for the fourth quarter and full year 2015 on Tuesday, March 29, 2016. Zosano will host a conference call and webcast to provide a corporate update at 4:30 p.m. ET (1:30 p.m. PT) that day. The call will be hosted by Konstantinos Alataris, Ph.D., President and CEO, and Winnie W. Tso, CFO.

To participate via live webcast, please enter this event link on your web browser: http://edge.media-server.com/m/p/7md8rj2v.

To participate on the live call, please dial +1 (866) 410-5537 (domestic) or +1 (704) 908-0329 (international), and provide the conference ID 55587751, approximately 5 to 10 minutes ahead of the start of the call.

About Zosano Pharma

Zosano Pharma Corporation is a clinical-stage specialty pharmaceutical company that has developed a proprietary transdermal microneedle patch system to deliver drug formulations through the skin for the treatment of a variety of indications. Zosano Pharma's microneedle patch system offers rapid onset, consistent drug delivery, improved ease of use and room-temperature stability, benefits that the company believes often are unavailable using oral formulations or injections. Zosano Pharma's microneedle patch system has the potential to deliver numerous medications for a wide variety of indications in commercially attractive markets. It has been tested in more than 400 patients with over 30,000 patches successfully applied to humans in Phase 1 and Phase 2 clinical studies. Learn more at www.zosanopharma.com.

Zosano Contact:.
Konstantinos Alataris, Ph.D.
Chief Executive Officer
510-745-1200

Investor Contact:
Patti Bank
Westwicke Partners
415-513-1284
[email protected]

Media Contact:
Jamie Lacey-Moreira
410-299-3310
[email protected]